Inside This Issue:

4th All-Ireland Cancer Conference Heralded as Success

3rd All-Ireland Cancer Statistics Report Release

Cancer 2008

Cancer Genomics MasterClass

4th AICC Poster Winners

Partner Update

Consortium Leadership

Health Economics Workshop

IACR 2009 Annual Meeting

Announcements

What's Next

Please direct all communications to the Consortium at:

E-MAIL
consortium@cancer.gov

TELEPHONE
(from Ireland/Northern Ireland)
001-301-496-5534

ADDRESS
Ireland-Northern Ireland-NCI
Cancer Consortium
6130 Executive Blvd.
Suite 100
Bethesda, MD 20892

WEB SITE
http://www.allirelandnci.org

Cutting-edge research presented at Cancer Genomics MasterClass

Following the 4^th All-Ireland Cancer Conference (AICC), Trinity College Dublin (TCD) and St. James’s Hospital hosted a Cancer Genomics MasterClass, as part of the Dublin Region Higher Education Alliance (DRHEA), on 4 December 2008. The event drew over 70 delegates from various institutions to hear the latest developments in this fast-growing area of cancer research.

The MasterClass series, an innovative doctoral education program, was formally launched by Professor Carol O’Sullivan, Dean of Graduate Studies at TCD. She outlined how the DRHEA is striving to provide quality postgraduate education for PhD students in Ireland, adding that this MasterClass represents a pioneering way of exposing Irish scientists to high quality research.

Professor Mark Lawler, Consortium Scholar Exchange Working Group chair, director of Post Graduate Teaching and Learning, Trinity Centre for Health Sciences, St. James’s Hospital, and MasterClass organizer, commented that the MasterClass, “represented an excellent opportunity to hear the latest advances in genetic susceptibility to cancer. It provided an opportunity for postgraduate and postdoctoral students to meet with international experts in a workshop setting and it had the added advantage of expert critique of their work and advice from the distinguished MasterClass faculty.”

During the MasterClass, a number of selected attendees provided oral presentations. Topics included identifying genetic susceptibility to multiple myeloma, designing new technical approaches to detect genetic changes in cancer cells, developing a molecular algorithm for cervical cancer, and studying the genetics of inherited colon cancer.

Advancing the research community’s knowledge of the genomic architecture of cancer is critical to elucidating causes of the disease and translating research results for clinical benefit. The Cancer Genomics MasterClass provided a unique opportunity for students to share their expertise and learn more about cutting-edge research in this important field.